three of which target tumor necrosis factor (TNF). When considering the impact of biologic therapy on the management of IBD, it is important to consider the positioning of the biologic agents as ...

Table 1. Summary of biological therapies of inflammatory bowel disease. Target or supplement Agent name (nature) Application Usage Ref. Anti-TNF Infliximab (mAb) UC, CD, approved by US FDA iv.

Per os; sc.: Subcutaneous injection; UC: Ulcerative colitis. Numerous biological agents are currently available for the treatment of patients with inflammatory bowel disease (IBD). These agents ...